Companies · Other Health Care

Mitra RxDx, Inc.

WOBURN · Other Health Care

Diligence memoA one-page analyst read on Mitra RxDx, Inc. — recommendation, valuation, rhythm, risks.
$111.0M
Total raised · real
3
Rounds
1.0×
Latest step-up
Top 5%
Sector rank · raised
Series C
Latest stage · inferred · Wed Jul 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time)

Mitra RxDx, Inc. looks fair against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 0.96× the median modeled value of Series C Other Health Care companies in 2016–2018 (40 peers) — value vs value, same stage and era.
  • Within the normal band (96% of peer median) for its niche.
Dormant
  • Last raise 8.0 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Mitra RxDx, Inc. is one of 5377 Other Health Care companies tracked from WOBURN. By capital raised it ranks among the largest (ahead of 96% of sector peers), and among the largest by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
12
Investors (latest)
2016
Year incorporated
2018-07-11
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$500M$1.0B$1.5B$2.0BSeries B · 2016-08-23 Raised $26M (real) Modeled valuation $585M (est)$26M$585MSeries B2016Series C · 2018-07-11 Raised $44M (real) Modeled valuation $1.0B (est)$44M$1.0BSeries C2018Series C · 2018-07-11 Raised $41M (real) Modeled valuation $933M (est)$41M$933MSeries C2018Series C · 2018-07-11 Raised $41M (real) Modeled valuation $933M (est)$41M$933MSeries C2018+$44M+$41M+$41MCumulative $152M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series B$26.4M · 2016
Series C$43.8M · 2018
Series C extension$40.8M · 2018
Series C extension$40.8M · 2018

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed, Series A — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 40%.

Modeled valuation trajectory
$1.0B
Base estimate est.
$159.3M
Conservative case
$2.6B
Upside case
$292.2M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ca $40M–$100M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Series B · modeled $584.9M · 2016-08-232016Series C · modeled $1.0B · 2018-07-11Series C · modeled $933.3M · 2018-07-11Series C · modeled $933.3M · 2018-07-112018
Model inputs · modeled:benchmark-stage-stepup-v1
15%
Dilution assumption
Implied ownership sold in the financing.
73%
Survival probability
55% low · 85% high
1.29×/yr
Annual markup
1.48×/yr upside case
6.0 yr
Elapsed time used
8.0 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
8 mo
Avg between rounds
$59.0M/yr
Capital velocity
9.9 yr
On record since
2016
First round
4
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 46× above median
This company$111.0M
Sector median$2.4M
Latest round — vs other Series C rounds in sector (real $, this stage) 0.9× of median
This company$40.8M
Sector median$45.9M
Modeled value — vs sector median (estimate, all stages) 45× above median
This company$1.0B
Sector median$22.1M

Raised more than 96% of sector peers (real $). Modeled value above 97% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series C) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #25 of 40.

This companyCohort peer
$100.0M$1.0B$10.0B$10.0M$100.0M$1.0BCapital raised (log)Specialty Networks, LLC · Series C Raised $94.5M · modeled $2.2B (est)New MMI Holdings, Inc. · Series C Raised $80.7M · modeled $1.8B (est)BioMatrix Holdings, L.L.C. · Series C Raised $80.0M · modeled $1.8B (est)Sea Hunter Holdings, LLC · Series C Raised $76.3M · modeled $1.7B (est)Bind Benefits, Inc. · Series C Raised $70.0M · modeled $1.6B (est)Endotronix Inc · Series C Raised $116.1M · modeled $1.6B (est)Great Basin Scientific, Inc. · Series C Raised $124.3M · modeled $1.6B (est)TransMedics, Inc. · Series C Raised $249.0M · modeled $1.5B (est)Landmark Health, LLC · Series C Raised $90.8M · modeled $1.4B (est)Rapid Micro Biosystems, Inc. · Series C Raised $134.6M · modeled $1.4B (est)Mdp Acm Holdings, Llc · Series C Raised $60.0M · modeled $1.4B (est)ACON BioMatrix Investors I, L.L.C. · Series C Raised $57.5M · modeled $1.3B (est)Mitra RxDx, Inc. (this company) Raised $111.0M · modeled $1.0B (est)Mitra RxDx, Inc.
CompanyStageRaised · realValue · estvs peer med.
Specialty Networks, LLCSeries C$94.5M$2.2B2.08×
New MMI Holdings, Inc.Series C$80.7M$1.8B1.77×
BioMatrix Holdings, L.L.C.Series C$80.0M$1.8B1.76×
Sea Hunter Holdings, LLCSeries C$76.3M$1.7B1.68×
Bind Benefits, Inc.Series C$70.0M$1.6B1.54×
Endotronix IncSeries C$116.1M$1.6B1.52×
Great Basin Scientific, Inc.Series C$124.3M$1.6B1.49×
TransMedics, Inc.Series C$249.0M$1.5B1.40×
Landmark Health, LLCSeries C$90.8M$1.4B1.34×
Rapid Micro Biosystems, Inc.Series C$134.6M$1.4B1.32×
Mdp Acm Holdings, LlcSeries C$60.0M$1.4B1.32×
ACON BioMatrix Investors I, L.L.C.Series C$57.5M$1.3B1.26×
Mitra RxDx, Inc. this companySeries C$111.0M$1.0B0.96×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series B$26.4M2016-08-23$146.7M$584.9M85%
Series C$43.8M2018-07-11$292.2M$1.0B90%
Series C$40.8M2018-07-11$272.2M$933.3M90%
Series C$40.8M2018-07-11$272.2M$933.3M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series B$26.4M2016-08-23
    • First recorded raise — entered as Series B.
    • 7 investors on this round.
  2. Series C$43.8M2018-07-11
    • Raised again after 23 mo — slower than the ~14 mo sector norm.
    • Round 1.7× larger than the prior — scaling up.
    • 13 investors on this round.
  3. Series C$40.8M2018-07-11
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 12 investors on this round.
  4. Series C$40.8M2018-07-11
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 12 investors on this round.
Intelligence
2019 ~Q1
Modeled next raise · ~8mo cadence
$40.8M
Modeled next size est.range $40.8M$65.3M
1.0×
Last step-up
$59.0M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Charles L. Cooney3 other2018-07
Anjana Kumar Sasidharan2016-08
Barath Kumar Subramanian2018-07
Ian Kumar Radcliffe2018-07
Ian Kumar Ratcliffe2016-08
Mahendran Kumar Balachandran2016-08
Mallikarjun L. Sundaram2018-07
Mallikarjun Sundaram2016-08
Maneesh L. Arora2018-07
Michael L. Rubin2018-07
Pradip Kumar Majumder2016-08
Steven Coleman2018-07
Vineet Kumar Chadha2016-08
Registry & provenance

Mitra RxDx, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1681405
SEC CIK
2016
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Ready Responders, Inc.Other Health CareSeries C$110.3M$1.2Bsame sector · same stage
Procyrion, Inc.Other Health CareSeries C$112.0M$543.3Msame sector · same stage
Remedy Partners, Inc.Other Health CareSeries C$110.0M$1.4Bsame sector · same stage
Pill Club Holdings, Inc.Other Health CareSeries C$113.8M$757.8Msame sector · same stage
Get Heal, Inc.Other Health CareSeries C$114.6M$1.4Bsame sector · same stage
GCD ManageCo, LLCOther Health CareSeries C$115.1M$1.3Bsame sector · same stage
Endotronix IncOther Health CareSeries C$116.1M$1.6Bsame sector · same stage
AliveCor, Inc.Other Health CareSeries C$105.9M$1.2Bsame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
RxRevu, Inc.Other Health CareSeries A$49.5M88%
MedRx Global, Inc.Other Health CarePre-Seed$27.7M88%
RxAdvance CorpOther Health CareSeries C$1.1B87%
RxWare, Inc.Other Health CareSeries A$20.1M87%
NexGelRx, Inc.Other Health CareSeed$3.0M87%
RxLightning, Inc.Other Health CareSeries B$160.3M87%
Mitesco, Inc.Other Health CareSeries A$395K87%
Remedtx, Inc.Other Health CarePre-Seed$1.4M87%
Frequently asked
How much funding has Mitra RxDx, Inc. raised?
Mitra RxDx, Inc. has raised approximately $111.0M in disclosed capital across 3 recorded financing rounds, aggregated from public filings.
What is Mitra RxDx, Inc.'s estimated valuation?
Provath's modeled valuation for Mitra RxDx, Inc. is approximately $1.0B (modeled range $159.3M–$2.6B). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Mitra RxDx, Inc. at?
Mitra RxDx, Inc.'s latest modeled financing stage is Series C. Its most recent recorded round closed around Wed Jul 11.
What does Mitra RxDx, Inc. do and where is it based?
Mitra RxDx, Inc. operates in the Other Health Care sector, based in WOBURN.
Explore related

See where Mitra RxDx, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Mitra RxDx, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.